| Literature DB >> 36211686 |
Edidiong Orok1, Ekpedeme Ndem2, Eunice Daniel2.
Abstract
Objective: Vaccine development, distribution, and immunization of large populations have been identified as vital mitigation strategies for curbing the spread of COVID-19. However, vaccine hesitancy is a major barrier to this. The knowledge and perception of COVID-19 vaccines can improve vaccine acceptance. The purpose of this study was to assess medical students' knowledge, attitude, and perception of COVID-19 vaccines.Entities:
Keywords: COVID-19 vaccines; Nigeria; knowledge; medical students; perception
Mesh:
Substances:
Year: 2022 PMID: 36211686 PMCID: PMC9535657 DOI: 10.3389/fpubh.2022.942283
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Demographics of the study participants.
|
|
| |
|---|---|---|
| Gender | Male | 114 (48.9) |
| Female | 119 (51.1) | |
| Age | <18 years | 16 (6.9) |
| 18–27 Years | 213 (91.4) | |
| Above 27 years | 3 (1.3) | |
| Marital status | Single | 228 (97.9) |
| Married | 5 (2.1) | |
| Departments | Anatomy | 25 (10.7) |
| Biochemistry | 65 (27.9) | |
| Medicine and surgery | 100 (42.9) | |
| Physiology | 43 (18.5) | |
| Years of study | 100–300 level (Pre-Clinical) | 154 (66.1) |
| 400–600 level (clinical) | 79 (33.9) |
Knowledge statements of study participants.
|
|
|
| |
|---|---|---|---|
|
|
| ||
| 1 | COVID-19 is real and can get severe and cause death | 221 (94.8) | 12 (5.2) |
| 2 | Two doses given 8–12 weeks apart is the recommended dosing schedule for OXFORD/AstraZeneca COVID-19 vaccine | 101 (43.3) | 132 (56.6) |
| 3 | Adults >18 years, adults with co-morbidities, healthcare professionals with frequent patient contact and those currently diagnosed with COVID-19, should take COVID-19 vaccine | 68 (29.2) | 165 (70.8) |
| 4 | The number of doses for the AstraZeneca vaccine is 2 doses and it should be taken through the intramuscular route | 73 (31.3) | 160 (68.7) |
| 5 | I know how COVID-19 vaccines work | Yes | 96 (41.2) |
| No | 137 (58.8) | ||
| Mean Knowledge score ± | |||
| Knowledge categories | Excellent knowledge (>70%) | 6 (2.6) | |
| Good knowledge (50–69 %) | 48 (20.6) | ||
| Poor knowledge (<50%) | 179 (76.8) | ||
| Source of information by the participants | |||
| Information source | Frequency (%) | ||
| Print/Electronic media | 2 (0.8) | ||
| Friends and colleagues | 6 (2.4) | ||
| International and health organizations | 7(3.2) | ||
| Medical Journals | 8 (3.4) | ||
| Health professionals | 70 (30) | ||
| Social media | 140 (60) | ||
Perception of study participants on COVID-19 vaccine.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| 1 | COVID-19 vaccine is an effective way to control and prevent COVID-19 | 79 (33.9) | 97 (41.6) | 43 (18.5) | 10 (4.3) | 4 (1.7) |
| 2 | COVID-19 vaccines should be made compulsory for the general population | 45 (19.3) | 45 (19.3) | 58 (24.9) | 52 (22.3) | 33 (14.2) |
| 3 | COVID-19 vaccines are unsafe | 12 (5.2) | 25 (10.7) | 125 (53.6) | 49 (21.0) | 22 (9.4) |
| 4 | The vaccines are not necessary, the immune system is enough | 7 (3.0) | 24 (10.3) | 78 (33.5) | 75 (32.2) | 49 (21.0) |
| 5 | I am afraid that the vaccines might have unwanted side effects | 69 (29.6) | 95 (40.8) | 52 (22.3) | 12 (5.2) | 5 (2.1) |
| 6 | The benefit of the vaccines outweighs possible side effects | 49 (21.0) | 64 (27.5) | 92 (39.5) | 25 (10.7) | 3 (1.3) |
| 7 | I believe the vaccines would have future medical implications | 30 (12.9) | 41 (17.6) | 134 (57.5) | 17 (7.3) | 11 (4.7) |
|
|
| |||||
|
|
|
| ||||
| I will accept the COVID-19 vaccine |
|
|
| |||
| I will encourage others to accept COVID-19 vaccine |
|
|
| |||
SA, Strongly Agree=5; A, Agree=4; UN, Undecided=3; D, Disagree=2, SD, Strongly Disagree=1.
Association between knowledge scores, perception and demographics of participants.
|
|
|
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| |||||||||||
| Mean knowledge score ± | 4.16± 2.762 | 4.46 ±-2.732 | 0.405a | 4.23 ±-2.766 | 4.50 ± 3.109 | 0.845a | 4.30 ±-2.350 | 4.50 ± 3.091 | 0.089 | |||||||
| Positive perception | 63 | 56 | 0.962b | 117 | 2 | 0.991c | 71 | 44 | 0.567 | 60 | 40 | 3 | 5 | 1 | 1 | 0.567c |
| Negative perception | 60 | 54 | 112 | 2 | 83 | 35 | 80 | 20 | 5 | 2 | 5 | 1 | ||||
aIndependent sample t-test.
bPearson Chi-square test.
cFisher's Exact test.
SM, Social Media; HP, Health professionals; MJ, Medical Journals; IH, International&other health organizations; FC, Friends &colleagues; PM, Print/Electronic Media.